Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial

Timothy David Trojan, J. Andrew Bird

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)S48
JournalPediatrics
Volume132
Issue numberSUPPL.1
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this